Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcome

Podobne zapisy

• Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project
  od: Mora, Barbara, i wsp.
  Wydane: (2018)
• Recent advances in understanding myelofibrosis and essential thrombocythemia
  od: Vainchenker, William, i wsp.
  Wydane: (2016)
• Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients
  od: Qiao, Chun, i wsp.
  Wydane: (2014)
• The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis
  od: Hernández-Boluda, Juan-Carlos, i wsp.
  Wydane: (2014)
• The importance of cytogenetics in polycythemia vera, primary myelofibrosis and essential thrombocythemia
  od: Monika Conchon
  Wydane: (2011-12-01)